MDxHealth SA reports results for the quarter ended in September 30 - Earnings Summary

MDxHealth SA

07/11/2024 04:55

* MDxHealth SA  MDXH.OQ  reported a quarterly adjusted loss
of 40
cents​​ per share for the quarter ended September 30, identical
to the same quarter last year.  The mean expectation of
five analysts for the quarter was for a loss of 27 cents per
share. Wall Street expected results to range from -30 cents
to -25 cents per share.
    * Revenue rose 20.5% to $23.32 million from a year ago;
analysts
expected $21.48 million. 
    * MDxHealth SA's reported EPS for the quarter was a loss
of 40
cents​.
    * The company reported a quarterly loss of $11.19 million.
    * MDxHealth SA shares had fallen by 0.5% this quarter and
lost 47.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 17.4%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 7 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for MDxHealth SA is
7.00 
This summary was machine generated from LSEG data November 7 at
04:54 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.27          -0.40          Missed
 Jun. 30 2024      -0.26          -0.42          Missed
 Mar. 31 2024      -0.30          -0.31          Missed
 Dec. 31 2023      -0.11          -0.39          Missed